RUNX2 and atherosclerosis: Mutation of serine 510 and activated STAT-1 protein inhibitor inhibited metformin-induced Runx2-SUMO and blocked the effect of metformin on the reduction of Runx2 expression in new vascular smooth muscle cells triggered by oxidized low-density lipoprotein, thereby promoting atherosclerotic calcification of atherosclerosis [42].